Saturday, August 8, 2015

The Result of Irrationality

8/8/15

“Markets can remain irrational longer than you can remain solvent.” That was the famous quote of notorious British economist, John Maynard Keynes. That also seems to be the theme of the US stock market over the last 6 weeks. Technicals and momentum has taken the stock market hostage and investors are looking for any tiny reason to sell stocks. Profit taking is normal in the marketplace, but this is mass selling of stocks reporting great numbers and strong future growth. Instead of selling Netflix after they reported a huge YoY DROP in earnings, investors chose to bid it up to where it now trades at 430x FY16 earnings (that’s right, a GROWTH company that’s been around for 18 years is only expected to make a whopping $0.33/share in ALL of 2016). Instead of buying Apple, Gilead, Time Warner, and UnitedHealthGroup, which all trade at ridiculously low valuations and reported great quarters, investors sold with both hands, sending a couple of those names into a correction.

This irrationality is actually something than a rational investor (hopefully all of you) can use to your advantage. Instead of just selling because everyone else is, spend time to read through the conference calls, and often times you will find the selling is overdone. Take Disney for instance…the company reported an earnings beat and quarterly revenues were essentially in-line with estimates. However, since management said that they see “some cord cutting” and anticipate less revenues going forward for their ESPN division, the stock suffered a 9% drop in a single session. Although everything else was great in the quarter, and everything else going forward is going to be great, investors keyed on that one phrase and completely forgot about Star Wars, Shanghai Disney, Frozen, Marvel, and everything else that comes along with the company. The stock spent the next three days in the dog house, falling about 10% and as much as 14% at one point. That sell-off gave you (and still gives you) a great entry point.

This recent love fest for the momentum names right now is what’s dragging the market down. Investors are taking profits where they have them and are putting their money to work in the likes of Amazon, Netflix and Shake Shack for fearing of missing out on the big gains. But like I said, you should use that to your advantage. Don’t assume that because a stock is going lower, that the company is broken. Despite what BofA says in their downgrade of Apple this week, there is nothing to indicate that Apple should be worth 12% less today than it was before it reported an EPS, revenue and margin beat. I’m sorry they only sold 47.5M iPhones (the most ever in Q3, which is always their weakest quarter) when analysts were expecting 49M. Time Warner reported a huge EPS and revenue beat and reaffirmed FY guidance, however since they didn’t give any Q3 guidance (which by the way, they never have), the stock got crushed on worries that too many consumers were cutting the cord on cable bundles. If Disney had not warned on slowing ESPN revenue, I believe Time Warner would actually have been UP this week, not down as much as 15% in less than 2 days.

That’s why it’s important to use rationality when you’re investing. Instead of shooting first and asking questions later, read through what management actually says, or what the analyst report says who upgraded or downgraded a stock. Case in point: On June 19th, Citron Research, a notorious short-seller, put out a note on semiconductor stock, Ambarella, saying its share price is “ridiculous” and that “Ambarella’s parabolic frenzy has now launched it into a realm that can’t possibly be supported by reality.” That note alone sent everyone running for the hills, dropping the stock 26% in a day. Now, at that point, the stock had rallied about 148% this year, but it was only trading at 31x FY17 (currently in Q2 of FY16) EPS. So Citron is disgusted with a forward P/E of 31 for a company involved in making chips for drones, which seems to be a big part of the future, but they’re okay with Netflix, which is also up 136% YTD and trades at almost 450x next year’s earnings. They must also be okay with Shake Shack rallying 110% in the first 4.5 months of going public and trading at about 450x next year’s earnings. That makes sense. If you listened to the folks over at Citron, you would have missed out on a 36% rally back to new all-time highs, just 30 days later.

Along with irrationality, fundamentals have been wiped out of the equation altogether, and instead technicals are the only thing that investors are trading on. With Apple, all you heard about this week was that it broke the 200-day moving average. I’m sure you also heard about the S&P having to hold the 200-day moving average at least 10 or 12 times this week too. While I am a strong believer in technicals, even more so than fundamentals, I also believe that both are important and both need to be used. The fundamentals will help you determine which stocks to buy, and the technicals will help you determine entry and exit points. So to put you on an even playing field, the only level in the S&P that you need to know is 2073, which is the 200-day moving average and is a level only broken twice (three times if you include Friday) in the last year. The first time was during last October’s sell-off, where the market dropped 9.4% and then most recently in early July when the market fell about 4% from peak to trough. The latter time, the S&P only traded below the 200 day for two days before rallying back towards all-time highs. On Friday, the S&P pierced the 2073 level, but finished the day strong to close at 2078.

Early in the year, while analysts across the board were calling for a market correction, I insisted it wasn’t going to happen because the Biotech ETF (IBB) and the Russell 2000 (IWM) held their key technical levels, the infamous 200-day moving average). However, on Friday, that all changed when the IWM closed at $119.93, its lowest close since December. Although, that’s a bad sign, since the Russell 2000 has been a leader during this 7-year bull market, I am not as concerned because the Biotechs are still holding up strong. So despite the hit to your portfolio over the last two weeks, you should still be in pretty good shape, as long as the IBB can stay firm. The 100-day on the IBB is $364, which held strong on Friday’s drop. If the IBB closes below that level for three straight days, the markets will be in serious trouble because the only support below is at $339, which would be a 15% drop from all-time highs.

So to recap the key technical levels to watch: S&P 500 – 2073, IBB – 364, IWM – 120. Three straight closes below those levels will spell serious short-term trouble for the stock market. But long-term, it’s a healthy pullback. For the markets to really fall, all three have to break down, otherwise, you’ll still in good shape, but keep your stock shopping list handy. 

There is and will always be irrationality in the marketplace. But how you handle that irrationality is what will be the difference between outperformance and underperformance. Don’t just assume the company is broken and the stock should be sold, just because it’s going lower or because someone says to sell it. Do your own research and as long as nothing has materially changed for worse, you should be a buyer.  

I made some changes to my portfolio this week, most notably cutting my big losses in Twitter and energy. I sold completely out of Twitter on Monday and exited my entire positions in ConocoPhillips, EOG Resources and Marathon Oil. At the same time, I took advantage of a correction in Disney (DIS), buying shares post-earnings, along with buying Skyworks Solutions (SWKS) early in the week on a sell-off.

My current positions: Long Gilead Sciences (GILD), Starbucks (SBUX), Facebook (FB), Wells Fargo (WFC), Time Warner (TWX), NXP Semiconductors (NXPI), Darden Restaurants (DRI), Celgene (CELG), Mobileye (MBLY), Jack In The Box (JACK), Under Armour (UA), United Rentals (URI), Regeneron (REGN), Apple (AAPL), Southwest Airlines (LUV), Dow Chemical (DOW), L Brands (LB), Costco (COST), Amgen (AMGN), Home Depot (HD), Allergan (AGN), FireEye (FEYE), Humana (HUM), GoPro (GPRO), Skyworks Solutions (SWKS), Disney (DIS) and long LAS VEGAS SANDS (LVS) CALLS.

Jeff Lewison


No comments:

Post a Comment